ELAVAY / Sample Intelligence
What the data actually says
A glimpse of real ELAVAY findings, the kind of evidence that turns a resourcing conversation into a strategic decision. These are samples; your reports are specific to your communities.
0%
of advocates rate non-medical switching as a high-impact barrier to care.
0%
see limited patient education about copay-assistance programs.
0%
of materials are written above a 5th-6th-grade reading level.
Top barriers to access
Share of advocates rating each as high-impact · sample
Risk, barrier to access
BioAdvocate team scope
Avg. advocacy headcount by number of disease states · sample
Informational, team scale
In their words
The verbatims behind the numbers
Qualitative depth is where ELAVAY earns its trust. A few representative advocate voices.
"Until you know the community's perception, you really don't know if you're effective."
Advocacy Leader · Sample ELAVAY interview
"The granular comments give us better insight into the challenges patients actually face."
Advocacy Leader · Sample ELAVAY interview
Want the full sample report?
Get a representative 2025 ELAVAY sample, methodology, benchmark tables, and need-gap analysis, sent to your inbox.
See your numbers
This is what a sample looks like. Your ELAVAY reports speak directly to your disease areas and communities.